CClinicalTrials.gg
Status unknownNCT01494389Updated Dec 19, 2011

The Changes of CD4+T Lymphocyte Subsets in Septic Patients

An observational study in Sepsis and SIRS(Systemic Inflammatory Response Syndrome), sponsored by Chinese PLA General Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-12-19.

Sponsored by Chinese PLA General Hospital · Observational

The sponsor has not verified this record recently (last verified Jul 2011), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to explore the value of CD4+T lymphocyte subsets in cell immunity in the patients with sepsis.There are immunoparalysis in septic patients,the important player is the change of CD4+T lymphocyte,this immunoparalysis state contribute to the illness progress and outcome. Comprehend the change regularity of septic patients' cell immunity can guide fiter and correcter treatment.

02

Conditions studied

  • Sepsis
  • SIRS(Systemic Inflammatory Response Syndrome)

Keywords

  • CD4+T lymphocyte subsets
  • sepsis
  • immunoparalysis
03

In context

Sepsis

1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.

Browse Sepsis studies →

Lead sponsor

Chinese PLA General Hospital is the lead sponsor of 558 studies on the registry; 202 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All subjects were selected from among inpatients who were hospitalized between March 2010 and March 2011 in the Respiratory ICU, Surgical ICU, and Emergency ICU, Chinese People's Liberation Army (CPLA) General Hospital.

Inclusion criteria

  • Male and female aged 18 years old and over;
  • Fulfilled at least two criteria of systemic inflammatory response syndrome (a) core temperature higher than 38 °C or lower than 36 °C (b)respiratory rate above 20/min, or PCO2 below 32 mmHg (c) pulse rate above 90/min, and (d) white blood cell count greater than 12,000/μl or lower than \< 4,000/μl or less than 10% of bands.
  • Clinically suspected infection;

Exclusion criteria

Exclusion Criteria:

  • were under 18 years of age;
  • were refused by the patients or his/her familiality;
  • were suffering from acquired immunodeficiency syndrome,virlhepatitis,autoimmune diseases and hematology;
  • use medicine which can affect immune system,such as Glucocorticoid and Immunosuppressant
  • died within 24h after being taken into the ICU, or refused to get involved in the study, or gave up treatment during the period of observation
05

Study design

Observational model
Case-control
Time perspective
Prospective

Groups and cohorts

  • SIRS

    (1) temperature \> 38oC or \< 36oC; (2) pulse rate \> 90 beats/min; (3) ventilation rate \> 20 breaths/min or hyperventilation with a partial pressure of arterial carbon dioxide (PaCO2) \< 32 mmHg; (4) white blood cell (WBC) count \>1 2,000μL-1 or \< 4000 μL-1 , or \> 10% immature cells.

  • sepsis

    SIRS + infection

  • Normal

    not SIRS and have no infection

06

Study locations

1 site
  • Chinese PLA General Hospital
    Beijing, Beijing 100853, China
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01494389
Lead sponsor
Chinese PLA General Hospital
First posted
Dec 19, 2011
Start date
Aug 2011
Primary completion
Mar 2012 (estimated)
Completion
Mar 2012 (estimated)
Last update
Dec 19, 2011

Study contacts

Xie Li Xin, Doctor
study director · Department Of Respiratory Diseases, Chinese PLA General Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion